{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T05:41:41Z","timestamp":1654926101771},"reference-count":32,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":2534,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002655","name":"Terry Fox Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002655","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","exphem.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.exphem.2015.04.004","type":"journal-article","created":{"date-parts":[[2015,5,4]],"date-time":"2015-05-04T05:33:01Z","timestamp":1430717581000},"page":"514-523.e2","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Dominant-negative IKAROS enhances IL-3-stimulated signaling in wild-type but not BCR-ABL1+ mouse BA\/F3 cells"],"prefix":"10.1016","volume":"43","author":[{"given":"Sofia","family":"von Palffy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Bulaeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonja","family":"Babovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nagarajan","family":"Kannan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.H.F.","family":"Knapp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Connie J.","family":"Eaves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip A.","family":"Beer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2015.04.004_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1615\/CritRevOncog.v16.i1-2.20","article-title":"Ikaros and tumor suppression in acute lymphoblastic leukemia","volume":"16","author":"Payne","year":"2011","journal-title":"Crit Rev Oncog"},{"key":"10.1016\/j.exphem.2015.04.004_bib2","first-page":"3931","article-title":"Decreases in Ikaros activity correlate with blast crisis in patients with chronic myelogenous leukemia","volume":"59","author":"Nakayama","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2015.04.004_bib3","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature06866","article-title":"BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros","volume":"453","author":"Mullighan","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2015.04.004_bib4","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1182\/blood-2007-09-112631","article-title":"Expression of spliced oncogenic Ikaros isoforms in Philadelphia-positive acute lymphoblastic leukemia patients treated with tyrosine kinase inhibitors: Implications for a new mechanism of resistance","volume":"112","author":"Iacobucci","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.04.004_bib5","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.3324\/haematol.13260","article-title":"Identification of different Ikaros cDNA transcripts in Philadelphia-positive adult acute lymphoblastic leukemia by a high-throughput capillary electrophoresis sizing method","volume":"93","author":"Iacobucci","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2015.04.004_bib6","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1200\/JCO.1999.17.12.3753","article-title":"Expression of aberrantly spliced oncogenic Ikaros isoforms in childhood acute lymphoblastic leukemia","volume":"17","author":"Sun","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2015.04.004_bib7","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1182\/blood-2011-03-341412","article-title":"Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: A report from the Children's Oncology Group","volume":"118","author":"Zhang","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.04.004_bib8","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/leu.2010.298","article-title":"A deep-sequencing study of chronic myeloid leukemia patients in blast crisis (BC-CML) detects mutations in 76.9% of cases","volume":"25","author":"Grossmann","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2015.04.004_bib9","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S1074-7613(00)80269-1","article-title":"Selective defects in the development of the fetal and adult lymphoid system in mice with an Ikaros null mutation","volume":"5","author":"Wang","year":"1996","journal-title":"Immunity"},{"key":"10.1016\/j.exphem.2015.04.004_bib10","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.molimm.2011.03.006","article-title":"The Ikaros gene family: Transcriptional regulators of hematopoiesis and immunity","volume":"48","author":"John","year":"2011","journal-title":"Mol Immunol"},{"key":"10.1016\/j.exphem.2015.04.004_bib11","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1080\/10428190801993462","article-title":"Ikaros dominant negative isoform (Ik6) induces IL-3-independent survival of murine pro-B lymphocytes by activating JAK-STAT and up-regulating Bcl-xl levels","volume":"49","author":"Kano","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.exphem.2015.04.004_bib12","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/leu.2010.99","article-title":"Deletions of the transcription factor Ikaros in myeloproliferative neoplasms","volume":"24","author":"Jager","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2015.04.004_bib13","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.stemcr.2014.09.006","article-title":"A dominant-negative isoform of IKAROS expands primitive normal human hematopoietic cells","volume":"3","author":"Beer","year":"2014","journal-title":"Stem Cell Reports"},{"key":"10.1016\/j.exphem.2015.04.004_bib14","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1182\/blood-2014-06-581173","article-title":"Disruption of IKAROS activity in primitive chronic phase CML cells mimics myeloid disease progression","volume":"125","author":"Beer","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.04.004_bib15","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/309126a0","article-title":"Interleukin-3 supports growth of mouse pre-B-cell clones in\u00a0vitro","volume":"309","author":"Palacios","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2015.04.004_bib16","doi-asserted-by":"crossref","first-page":"9312","DOI":"10.1073\/pnas.85.23.9312","article-title":"Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210bcr\/abl protein","volume":"85","author":"Daley","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2015.04.004_bib17","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.ymthe.2006.02.013","article-title":"In\u00a0vivo transduction by intravenous injection of a lentiviral vector expressing human ADA into neonatal ADA gene knockout mice: A novel form of enzyme replacement therapy for ADA deficiency","volume":"13","author":"Carbonaro","year":"2006","journal-title":"Mol Ther"},{"key":"10.1016\/j.exphem.2015.04.004_bib18","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1128\/jvi.69.2.748-755.1995","article-title":"Multiple modifications in cis elements of the long terminal repeat of retroviral vectors lead to increased expression and decreased DNA methylation in embryonic carcinoma cells","volume":"69","author":"Challita","year":"1995","journal-title":"J Virol"},{"key":"10.1016\/j.exphem.2015.04.004_bib19","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1172\/JCI200421838","article-title":"High-level beta-globin expression and preferred intragenic integration after lentiviral transduction of human cord blood stem cells","volume":"114","author":"Imren","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2015.04.004_bib20","doi-asserted-by":"crossref","first-page":"4149","DOI":"10.1128\/MCB.00224-10","article-title":"Ikaros and Aiolos inhibit pre-B-cell proliferation by directly suppressing c-Myc expression","volume":"30","author":"Ma","year":"2010","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.exphem.2015.04.004_bib21","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1182\/blood-2012-08-450114","article-title":"Genome-wide identification of Ikaros targets elucidates its contribution to mouse B-cell lineage specification and pre-B-cell differentiation","volume":"121","author":"Ferreiros-Vidal","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.04.004_bib22","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-2141.2004.04854.x","article-title":"Overexpression of the Ikaros 6 isoform is restricted to t(4;11) acute lymphoblastic leukaemia in children and infants and has a role in B-cell survival","volume":"125","author":"Ruiz","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2015.04.004_bib23","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nmeth872","article-title":"Fluorescent cell barcoding in flow cytometry allows high-throughput drug screening and signaling profiling","volume":"3","author":"Krutzik","year":"2006","journal-title":"Nat Methods"},{"key":"10.1016\/j.exphem.2015.04.004_bib24","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0301-472X(01)00787-1","article-title":"Constitutive activation of STAT3 and STAT5 is induced by leukemic fusion proteins with protein tyrosine kinase activity and is sufficient for transformation of hematopoietic precursor cells","volume":"30","author":"Spiekermann","year":"2002","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2015.04.004_bib25","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/bjh.12301","article-title":"Does BCR\/ABL1 positive acute myeloid leukaemia exist?","volume":"161","author":"Nacheva","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2015.04.004_bib26","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1084\/jem.20090004","article-title":"Pre-B cell receptor-mediated cell cycle arrest in Philadelphia chromosome-positive acute lymphoblastic leukemia requires IKAROS function","volume":"206","author":"Trageser","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.exphem.2015.04.004_bib27","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/ni862","article-title":"The adaptor protein SLP-65 acts as a tumor suppressor that limits pre-B cell expansion","volume":"4","author":"Flemming","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.exphem.2015.04.004_bib28","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S1074-7613(03)00142-0","article-title":"Distinct signaling requirements for Dmu selection, IgH allelic exclusion, pre-B cell transition, and tumor suppression in B cell progenitors","volume":"18","author":"Hayashi","year":"2003","journal-title":"Immunity"},{"key":"10.1016\/j.exphem.2015.04.004_bib29","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1182\/blood-2008-07-166355","article-title":"BLNK suppresses pre-B-cell leukemogenesis through inhibition of JAK3","volume":"113","author":"Nakayama","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.04.004_bib30","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/ng.2532","article-title":"The genomic landscape of\u00a0hypodiploid acute lymphoblastic leukemia","volume":"45","author":"Holmfeldt","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.exphem.2015.04.004_bib31","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1056\/NEJMoa0808253","article-title":"Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia","volume":"360","author":"Mullighan","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2015.04.004_bib32","doi-asserted-by":"crossref","first-page":"428","DOI":"10.3324\/haematol.2011.056135","article-title":"IKZF1 deletion is an independent predictor of outcome in pediatric acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol","volume":"98","author":"Dorge","year":"2013","journal-title":"Haematologica"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X15001307?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X15001307?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T05:04:00Z","timestamp":1654923840000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X15001307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0301472X15001307"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2015.04.004","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dominant-negative IKAROS enhances IL-3-stimulated signaling in wild-type but not BCR-ABL1+ mouse BA\/F3 cells","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2015.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown copyright \u00a9 2015 Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}